• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9 抑制 HIV-1 感染的多个步骤。

CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.

机构信息

1 MOH Key Laboratory of Systems Biology of Pathogens, Institute of Pathogen Biology, and Center for AIDS Research, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China .

2 Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China .

出版信息

Hum Gene Ther. 2018 Nov;29(11):1264-1276. doi: 10.1089/hum.2018.018. Epub 2018 May 9.

DOI:10.1089/hum.2018.018
PMID:29644868
Abstract

CRISPR/Cas9 is an adaptive immune system where bacteria and archaea have evolved to resist the invading viruses and plasmid DNA by creating site-specific double-strand breaks in DNA. This study tested this gene editing system in inhibiting human immunodeficiency virus type 1 (HIV-1) infection by targeting the viral long terminal repeat and the gene coding sequences. Strong inhibition of HIV-1 infection by Cas9/gRNA was observed, which resulted not only from insertions and deletions (indels) that were introduced into viral DNA due to Cas9 cleavage, but also from the marked decrease in the levels of the late viral DNA products and the integrated viral DNA. This latter defect might have reflected the degradation of viral DNA that has not been immediately repaired after Cas9 cleavage. It was further observed that Cas9, when solely located in the cytoplasm, inhibits HIV-1 as strongly as the nuclear Cas9, except that the cytoplasmic Cas9 does not act on the integrated HIV-1 DNA and thus cannot be used to excise the latent provirus. Together, the results suggest that Cas9/gRNA is able to target and edit HIV-1 DNA both in the cytoplasm and in the nucleus. The inhibitory effect of Cas9 on HIV-1 is attributed to both the indels in viral DNA and the reduction in the levels of viral DNA.

摘要

CRISPR/Cas9 是一种适应性免疫系统,细菌和古菌通过在 DNA 上产生特定的双链断裂来抵抗入侵的病毒和质粒 DNA。本研究通过靶向病毒长末端重复序列和基因编码序列,测试了该基因编辑系统对人类免疫缺陷病毒 1 型(HIV-1)感染的抑制作用。Cas9/gRNA 对 HIV-1 感染的强烈抑制作用不仅来自于 Cas9 切割导致的病毒 DNA 插入和缺失(indels),还来自于晚期病毒 DNA 产物和整合病毒 DNA 水平的显著降低。后一种缺陷可能反映了 Cas9 切割后未立即修复的病毒 DNA 的降解。进一步观察到,Cas9 仅位于细胞质中时,就像核 Cas9 一样强烈抑制 HIV-1,只是细胞质 Cas9 不能作用于整合的 HIV-1 DNA,因此不能用于切除潜伏的前病毒。总之,这些结果表明 Cas9/gRNA 能够在细胞质和细胞核中靶向和编辑 HIV-1 DNA。Cas9 对 HIV-1 的抑制作用归因于病毒 DNA 中的 indels 和病毒 DNA 水平的降低。

相似文献

1
CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection.CRISPR/Cas9 抑制 HIV-1 感染的多个步骤。
Hum Gene Ther. 2018 Nov;29(11):1264-1276. doi: 10.1089/hum.2018.018. Epub 2018 May 9.
2
Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.基因治疗与 CRISPR/Cas9 渐趋成熟,有望攻克 HIV。
AIDS Rev. 2017 Oct-Dec;19(3):167-172.
3
HIV-1 Employs Multiple Mechanisms To Resist Cas9/Single Guide RNA Targeting the Viral Primer Binding Site.HIV-1 利用多种机制抵抗 Cas9/单导向 RNA 靶向病毒引物结合位点。
J Virol. 2018 Sep 26;92(20). doi: 10.1128/JVI.01135-18. Print 2018 Oct 15.
4
CRISPR/Cas9 Ablation of Integrated HIV-1 Accumulates Proviral DNA Circles with Reformed Long Terminal Repeats.CRISPR/Cas9 靶向整合的 HIV-1 会导致前病毒 DNA 环与重组长末端重复序列积累。
J Virol. 2021 Nov 9;95(23):e0135821. doi: 10.1128/JVI.01358-21. Epub 2021 Sep 22.
5
A CRISPR/Cas9 guidance RNA screen platform for HIV provirus disruption and HIV/AIDS gene therapy in astrocytes.一种基于 CRISPR/Cas9 指导 RNA 的 HIV 前病毒破坏筛选平台,用于星形胶质细胞中的 HIV/AIDS 基因治疗。
Sci Rep. 2017 Jul 20;7(1):5955. doi: 10.1038/s41598-017-06269-x.
6
Host Double Strand Break Repair Generates HIV-1 Strains Resistant to CRISPR/Cas9.宿主双链断裂修复会产生对 CRISPR/Cas9 有抗性的 HIV-1 株。
Sci Rep. 2016 Jul 12;6:29530. doi: 10.1038/srep29530.
7
Multiplexed Simian Immunodeficiency Virus-Specific Paired RNA-Guided Cas9 Nickases Inactivate Proviral DNA.多重串联的猴免疫缺陷病毒特异性 RNA 引导的 Cas9 切口酶使前病毒 DNA 失活。
J Virol. 2021 Nov 9;95(23):e0088221. doi: 10.1128/JVI.00882-21. Epub 2021 Sep 22.
8
A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.一种组合式 CRISPR/Cas9 基因编辑方法可阻断 HIV 复制并防止病毒逃逸。
Sci Rep. 2017 Feb 8;7:41968. doi: 10.1038/srep41968.
9
CRISPR/Cas9-Based Genome Editing of Transcription Factor Genes in Marchantia polymorpha.基于CRISPR/Cas9对多歧藻苔转录因子基因进行基因组编辑
Methods Mol Biol. 2018;1830:109-126. doi: 10.1007/978-1-4939-8657-6_7.
10
Viral diversity is an obligate consideration in CRISPR/Cas9 designs for targeting the HIV reservoir.病毒多样性是针对 HIV 储存库的 CRISPR/Cas9 设计中必须考虑的因素。
BMC Biol. 2018 Jul 11;16(1):75. doi: 10.1186/s12915-018-0544-1.

引用本文的文献

1
Mechanisms of Immune Evasion in HIV-1: The Role of Virus-Host Protein Interactions.HIV-1免疫逃逸机制:病毒-宿主蛋白相互作用的作用
Curr Issues Mol Biol. 2025 May 16;47(5):367. doi: 10.3390/cimb47050367.
2
Unlocking the potential: advancements and applications of gene therapy in severe disorders.释放潜能:基因疗法在严重疾病中的进展与应用
Ann Med. 2025 Dec;57(1):2516697. doi: 10.1080/07853890.2025.2516697. Epub 2025 Jun 17.
3
CRISPR-Cas12b enables a highly efficient attack on HIV proviral DNA in T cell cultures.CRISPR-Cas12b 可在 T 细胞培养物中高效靶向 HIV 前病毒 DNA。
Biomed Pharmacother. 2023 Sep;165:115046. doi: 10.1016/j.biopha.2023.115046. Epub 2023 Jun 28.
4
CRISPR/Cas9: a tool to eradicate HIV-1.CRISPR/Cas9:一种清除 HIV-1 的工具。
AIDS Res Ther. 2022 Dec 1;19(1):58. doi: 10.1186/s12981-022-00483-y.
5
Inhibition of HIV-1 replication using the CRISPR/cas9-no NLS system as a prophylactic strategy.使用CRISPR/cas9-无核定位信号系统抑制HIV-1复制作为一种预防策略。
Heliyon. 2022 Aug 31;8(9):e10483. doi: 10.1016/j.heliyon.2022.e10483. eCollection 2022 Sep.
6
Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections.CRISPR-Cas 基因组编辑技术在人类病毒感染中的治疗潜力。
Biomed Pharmacother. 2022 Apr;148:112743. doi: 10.1016/j.biopha.2022.112743. Epub 2022 Feb 25.
7
Pathways Toward a Functional HIV-1 Cure: Balancing Promise and Perils of CRISPR Therapy.迈向功能性 HIV-1 治愈的途径:平衡 CRISPR 治疗的前景与风险。
Methods Mol Biol. 2022;2407:429-445. doi: 10.1007/978-1-0716-1871-4_27.
8
Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics.CRISPR-Cas基因编辑技术在临床疾病治疗中的应用与挑战
Precis Clin Med. 2021 Jul 10;4(3):179-191. doi: 10.1093/pcmedi/pbab014. eCollection 2021 Sep.
9
CRISPR-Cas based virus detection: Recent advances and perspectives.基于 CRISPR-Cas 的病毒检测:最新进展与展望。
Biosens Bioelectron. 2021 Dec 1;193:113541. doi: 10.1016/j.bios.2021.113541. Epub 2021 Aug 8.
10
Inactivation of Latent HIV-1 Proviral DNA Using Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Treatment and the Assessment of Off-Target Effects.使用成簇规律间隔短回文重复序列/ Cas9 处理使潜伏性 HIV-1 前病毒 DNA 失活及脱靶效应评估
Front Microbiol. 2021 May 26;12:629153. doi: 10.3389/fmicb.2021.629153. eCollection 2021.